Clinical trial NCT02498353 - References

Rectal Cancer — Comparing Preoperative Short-course Radiotherapy With or Without Local Boost for Rectal Cancer

Citation(s)

•   Bujko K, Partycki M, Pietrzak L
  Neoadjuvant radiotherapy (5 × 5 Gy): immediate versus delayed surgery. Recent Results Cancer Res. 2014;203:171-87. doi: 10.1007/978-3-319-08060-4_12. Review.
•   Faria S, Kopek N, Hijal T, Liberman S, Charlebois P, Stein B, Meterissian S, Meguerditchian A, Fawaz Z, Artho G
  Phase II trial of short-course radiotherapy followed by delayed surgery for locoregionally advanced rectal cancer. Colorectal Dis. 2014 Feb;16
•   Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U
  Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005 Aug 20;23(24):5644-50.
•   Guckenberger M, Saur G, Wehner D, Thalheimer A, Kim M, Germer CT, Flentje M
  Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Radiother Oncol. 2013 Aug;108(2):326-3
•   Inra JA, Syngal S
  Colorectal cancer in young adults. Dig Dis Sci. 2015 Mar;60(3):722-33. doi: 10.1007/s10620-014-3464-0. Epub 2014 Dec 6. Review.
•   Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA, McKendrick J, Leong T, Hartopeanu C, Zalcberg J, Mackay J
  Randomized trial of short-course radiotherapy versus long-course chemoradiation
•   Ortholan C, Romestaing P, Chapet O, Gerard JP
  Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial. Int J Radiat Oncol Biol P
•   Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group
  The TME trial after a median follow-up of 6 years: increased local control but no surviva
•   Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group
  Preoperative versus postoperative chemoradiotherapy for rectal
•   Sauer R, Fietkau R, Wittekind C, Rödel C, Martus P, Hohenberger W, Tschmelitsch J, Sabitzer H, Karstens JH, Becker H, Hess C, Raab R; German Rectal Cancer Group
  Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German tri
•   Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C
  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the Germ
•   Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M
  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with r
•   van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ; Dutch Colorectal Cancer Group
  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 1

Preoperative Short-course Radiotherapy With Local Boost Versus Conventional Preoperative Short-course Radiotherapy for Rectal Cancer

Details for clinical trial NCT02498353